Literature DB >> 21431390

Robotic high-intensity focused ultrasound for prostate cancer: what have we learned in 15 years of clinical use?

Christian G Chaussy1, Stefan F Thüroff.   

Abstract

High-intensity focused ultrasound (HIFU) is an emerging, noninvasive, local treatment of prostate cancer with 15 years of clinical experience, during which about 30,000 HIFU treatments have been performed worldwide. In this paper, we review relevant publications regarding the means by which new and old prostate cancer technologies are evaluated, the outcomes of HIFU by Ablatherm (EDAP TMS, Lyon, France), and the evolution currently underway regarding how prostate cancer is diagnosed and treated. We show the potential of HIFU to be used as local therapy for men with any stage of prostate cancer and how this additional therapeutic option can fit within the future armamentarium of a sequential multimodal therapy concept.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21431390     DOI： 10.1007/s11934-011-0184-2

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN： 1527-2737            Impact factor:   3.092


  39 in total

1.  Multicentric oncologic outcomes of high-intensity focused ultrasound for localized prostate cancer in 803 patients.

Authors:  Sebastien Crouzet; Xavier Rebillard; Daniel Chevallier; Pascal Rischmann; Gilles Pasticier; Gregory Garcia; Olivier Rouviere; Jean-Yves Chapelon; Albert Gelet
Journal:  Eur Urol       Date:  2010-07-03       Impact factor: 20.096

2.  Results and side effects of high-intensity focused ultrasound in localized prostate cancer.

Authors:  C Chaussy; S Thüroff
Journal:  J Endourol       Date:  2001-05       Impact factor: 2.942

3.  Careful selection and close monitoring of low-risk prostate cancer patients on active surveillance minimizes the need for treatment.

Authors:  Mark S Soloway; Cynthia T Soloway; Ahmed Eldefrawy; Kristell Acosta; Bruce Kava; Murugesan Manoharan
Journal:  Eur Urol       Date:  2010-08-20       Impact factor: 20.096

4.  Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial.

Authors:  Anna Bill-Axelson; Lars Holmberg; Frej Filén; Mirja Ruutu; Hans Garmo; Christer Busch; Stig Nordling; Michael Häggman; Swen-Olof Andersson; Stefan Bratell; Anders Spångberg; Juni Palmgren; Hans-Olov Adami; Jan-Erik Johansson
Journal:  J Natl Cancer Inst       Date:  2008-08-11       Impact factor: 13.506

5.  High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure.

Authors:  Andreas Blana; Stephen C W Brown; Christian Chaussy; Giario N Conti; James A Eastham; Roman Ganzer; Francois J Murat; Gilles Pasticier; Xavier Rebillard; John C Rewcastle; Cary N Robertson; Stefan Thuroff; John F Ward
Journal:  BJU Int       Date:  2009-04-17       Impact factor: 5.588

6.  Nomogram use for the prediction of indolent prostate cancer: impact on screen-detected populations.

Authors:  Stijn Roemeling; Monique J Roobol; Michael W Kattan; Theo H van der Kwast; Ewout W Steyerberg; Fritz H Schröder
Journal:  Cancer       Date:  2007-11-15       Impact factor: 6.860

Review 7.  [Transrectal high-intensity focused ultrasound for local treatment of prostate cancer. 2009 Update].

Authors:  C G Chaussy; S Thüroff
Journal:  Urologe A       Date:  2009-07       Impact factor: 0.639

8.  Focal cryosurgery followed by penile rehabilitation as primary treatment for localized prostate cancer: initial results.

Authors:  David S Ellis; Theodore B Manny; John C Rewcastle
Journal:  Urology       Date:  2007-12       Impact factor: 2.649

9.  Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes.

Authors:  Piyush K Agarwal; Natalia Sadetsky; Badrinath R Konety; Martin I Resnick; Peter R Carroll
Journal:  Cancer       Date:  2008-01-15       Impact factor: 6.860

10.  Investigation of HIFU-induced anti-tumor immunity in a murine tumor model.

Authors:  Zhenlin Hu; Xiao Yi Yang; Yunbo Liu; Georgy N Sankin; Eric C Pua; Michael A Morse; H Kim Lyerly; Timothy M Clay; Pei Zhong
Journal:  J Transl Med       Date:  2007-07-11       Impact factor: 5.531
View more
  4 in total

1.  Role of active surveillance and focal therapy in low- and intermediate-risk prostate cancers.

Authors:  Henk van der Poel; Laurence Klotz; Gerald Andriole; Abdel-Rahmène Azzouzi; Anders Bjartell; Olivier Cussenot; Freddy Hamdy; Markus Graefen; Paolo Palma; Arturo Rodriguez Rivera; Christian G Stief
Journal:  World J Urol       Date:  2015-06-03       Impact factor: 4.226

2.  Magnetic Nanoparticle-Mediated Heating for Biomedical Applications.

Authors:  Elyahb Allie Kwizera; Samantha Stewart; Md Musavvir Mahmud; Xiaoming He
Journal:  J Heat Transfer       Date:  2022-01-18       Impact factor: 2.021

3.  Quality of life and functional outcome after infravesical desobstruction and HIFU treatment for localized prostate cancer.

Authors:  G Hatiboglu; I V Popeneciu; M Deppert; J Nyarangi-Dix; B Hadaschik; M Hohenfellner; D Teber; S Pahernik
Journal:  BMC Urol       Date:  2017-01-11       Impact factor: 2.264

4.  Robotic Assisted Laparoscopic Prostatectomy after High Intensity Focused Ultrasound Failure.

Authors:  Leon Telis; Seyed Behzad Jazayeri; David B Samadi
Journal:  Case Rep Urol       Date:  2017-01-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.